Our top pick for
Red Violet, Inc is a software-application business based in the US. Red Violet shares (RDVT) are listed on the NASDAQ and all prices are listed in US Dollars. Red Violet employs 107 staff and has a trailing 12-month revenue of around USD$34.7 million.
|52-week range||USD$13.4906 - USD$28.89|
|50-day moving average||USD$24.4161|
|200-day moving average||USD$22.7377|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.829|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Revenue TTM||USD$34.7 million|
|Gross profit TTM||USD$18 million|
|Return on assets TTM||-9.47%|
|Return on equity TTM||-22.97%|
|Market capitalisation||USD$290.9 million|
TTM: trailing 12 months
There are currently 848,952 Red Violet shares held short by investors – that's known as Red Violet's "short interest". This figure is 1.5% down from 862,280 last month.
There are a few different ways that this level of interest in shorting Red Violet shares can be evaluated.
Red Violet's "short interest ratio" (SIR) is the quantity of Red Violet shares currently shorted divided by the average quantity of Red Violet shares traded daily (recently around 51545.355191257). Red Violet's SIR currently stands at 16.47. In other words for every 100,000 Red Violet shares traded daily on the market, roughly 16470 shares are currently held short.
However Red Violet's short interest can also be evaluated against the total number of Red Violet shares, or, against the total number of tradable Red Violet shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Red Violet's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Red Violet shares in existence, roughly 70 shares are currently held short) or 0.1218% of the tradable shares (for every 100,000 tradable Red Violet shares, roughly 122 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Red Violet.
Find out more about how you can short Red Violet stock.
We're not expecting Red Violet to pay a dividend over the next 12 months.
Over the last 12 months, Red Violet's shares have ranged in value from as little as $13.4906 up to $28.89. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Red Violet's is 0.7189. This would suggest that Red Violet's shares are less volatile than average (for this exchange).
Red Violet, Inc., a software and services company, specializes in data fusion and analytics providing cloud-based mission-critical information solutions to enterprises in the United States. It offers idiCORE, an investigative solution used to address various organizational challenges, which include due diligence, risk mitigation, identity authentication, and legislative compliance; and FOREWARN, an app-based solution that provides instant knowledge before face-to-face engagement with a consumer, and help professionals to identify and mitigate risk. The company serves financial services, insurance, healthcare, retail, and telecommunication companies; law enforcement and government agencies; and collections, corporate security, and investigative law firms, as well as various types of corporate risk for purposes, such as identity verification, risk assessment, fraud detection, and compliance. It markets its products and services through value-added distributors, resellers, and strategic partners; and trade shows and seminars, advertising, public relations, distribution of sales literature, and product specifications and ongoing communication with prospective clients, distributors, resellers, strategic partners, and installed base of current clients, as well as through direct sales. The company was founded in 2017 and is headquartered in Boca Raton, Florida.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.